Results 151 to 160 of about 9,290 (210)

Long-Acting Injectable HIV Therapy Outcomes Among Persons With HIV Who Have Adherence Challenges to Oral Antiretroviral Therapy. [PDF]

Clin Infect Dis
Hastie E, Hill L, Bamford L, Karim A, Martin TCS.   +4 more
europepmc   +1 more source

Prevalence and factors associated with hyperglycemia among children living with HIV on dolutegravir in Kabale district, southwestern Uganda. [PDF]

PLoS One
Idow LH, Nduhukire T, Ankunda S, Tumwesigire S, Nyeko F, Tumwine JK.   +5 more
europepmc   +1 more source

An ex vivo functional biomarker of treatment response in pediatric low-grade glioma. [PDF]

PLoS One
Artz NM, Mann B, Ebbs A, Darawsheh R, Dasari R, Adefolaju A, Bell N, Trembath D, Higgins D, Elton S, Baldwin A, Hingtgen S, Kram DE, Satterlee AB.   +13 more
europepmc   +1 more source

Precision-Cut Bladder Slices: A Novel Model for the Study of Bladder Fibrosis and Potential Anti-Fibrotic Agents. [PDF]

Int J Urol
Lu Y, Simonsen NP, Djurhuus JC, Olsen LH, Mutsaers HAM, Nørregaard R.   +5 more
europepmc   +1 more source

Pharmacokinetics of Perampanel in Danish Paediatric Patients With Epilepsy Based on Therapeutic Drug Monitoring. [PDF]

Basic Clin Pharmacol Toxicol
Angelucci S, Houlind MB, Hansen MS, Hansen AFH, Shorter JR, Bayat A.   +5 more
europepmc   +1 more source

Dolutegravir Inhibits Autophagy In Vitro in a Mouse Blood-Brain Barrier Model. [PDF]

FASEB J
Huang C, Qu QR, Bendayan R.
europepmc   +1 more source

Negative influence of age and low baseline CD4 on T helper cell recovery among HIV-infected individuals with fixed-dose combination of tenofovir disoproxil, lamivudine and dolutegravir. [PDF]

Front Public Health
Saravanan S, Vignesh R, Rengarajan S, Vivekanandan T, Yong YK, Varsha V, Mounika P, Sivamalar S, Vidya M, Shankar EM, Larsson M, Velu V, Raju S, Balakrishnan P, Nisha B, Venkateswaran AR, Kannan R.   +16 more
europepmc   +1 more source

Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i>^<i>V600E</i> Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H. [PDF]

JCO Precis Oncol
Salama AKS, Wang V, Macrae ER, Park JI, Chen HX, Gray RJ, McShane LM, Rubinstein LV, Patton D, Williams PM, Hamilton SR, Armstrong DK, Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT.   +18 more
europepmc   +1 more source

Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST Study. [PDF]

Clin Infect Dis
Loosli T, Bolton Moore C, Buzaalirwa L, Byakwaga H, Çelikağ İ, Chimbetete C, Ebasone PV, Giandhari J, Han N, Huwa J, Kasozi C, Mafoua A, Messou E, Minga A, Muula G, Muyindike W, Ndala ACM, Sauermann M, Semeere A, Singh L, Kouyos RD, Lessells R, Egger M.   +22 more
europepmc   +1 more source

Synthesis and NAD(P)H:Quinone oxidoreductase 1 inducer activity of acetamide and pyridine-3-carbonitrile derivatives [PDF]

, 2016
Alsaid, Mansour S., Dinkova-Kostova, Albena T., Ghorab, Mostafa M., Higgins, Maureen, Naser, Almoqbl A., Shahat, Abdelaaty A.   +5 more
core   +1 more source